[Federal Register Volume 81, Number 51 (Wednesday, March 16, 2016)]
[Notices]
[Pages 14134-14135]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-05944]
=======================================================================
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
Advisory Committee on the Medical Uses of Isotopes; Renewal
AGENCY: U.S. Nuclear Regulatory Commission.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) has determined
that the renewal of the Charter for the Advisory Committee on the
Medical Uses of Isotopes for the 2 year period commencing on March 10,
2016, is in the public interest, in connection with duties imposed on
the Commission by law. This action is being taken in accordance with
the Federal Advisory Committee Act, after consultation with the
Committee Management Secretariat, General Services Administration.
FOR FURTHER INFORMATION CONTACT: Sophie Holiday, Office of Federal and
State Materials and Environmental Management Programs, U.S. Nuclear
Regulatory Commission, Washington, DC 20555; Telephone (301) 415-7865;
email [email protected].
SUPPLEMENTARY INFORMATION: The purpose of the ACMUI is to provide
advice to NRC on policy and technical issues that arise in regulating
the medical use of byproduct material for diagnosis and therapy.
Responsibilities include providing guidance and comments on current and
proposed NRC regulations and regulatory guidance concerning medical
use; evaluating certain non-routine uses of byproduct material for
medical use; and evaluating training and experience of proposed
authorized users. The members are involved in preliminary discussions
of major issues in determining the need for changes in NRC policy and
regulation to ensure the continued safe use of byproduct
[[Page 14135]]
material. Each member provides technical assistance in his/her specific
area(s) of expertise, particularly with respect to emerging
technologies. Members also provide guidance as to NRC's role in
relation to the responsibilities of other Federal agencies as well as
of various professional organizations and boards.
Members of this Committee have demonstrated professional
qualifications and expertise in both scientific and non-scientific
disciplines including nuclear medicine; nuclear cardiology; radiation
therapy; medical physics; nuclear pharmacy; State medical regulation;
patient's rights and care; health care administration; and Food and
Drug Administration regulation.
Dated at Rockville, Maryland, this 10th day of March 2016.
For the Nuclear Regulatory Commission.
Andrew L. Bates,
Federal Advisory Committee Management Officer.
[FR Doc. 2016-05944 Filed 3-15-16; 8:45 am]
BILLING CODE 7590-01-P